Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Dead may feed during

In older-donor , retained dead-cell material may fuel extra survival or growth of an existing . Verified of its without loss of that extra output would bound the feeding contribution, provided injury responses and alternative nutrition remain intact.

Omega Point 1.5

Stage of verification

  1. Hypothesis published2026-10-10
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

Uptake and metabolic use of locally available nutrients by an invasive cell lineage in human epithelium, incorporating material into newly synthesized cellular components or breaking it down to support energy needs, cellular maintenance, survival and proliferation. The hypothesis proposes an additional contribution from dead resident cells during repair; this contribution remains unverified.Cellular nutrient utilization

Direction

Lens

Puts the cause in what the system spends, stores and runs short of.Resource and energy

Kind of knowledge gap

Established results make incompatible predictions.Clash gap

A double ring marks the main placement where a group contains several values.

Goal
Закрепление возрастных повреждений через преимущество дефектного обновления
Competing hypotheses
3
Published
2026-10-10
Engine version
Omega Point 1.5
As a hypothesis
10 / 10Clarity of mechanism
10 / 10Few extra conditions
6 / 10Completeness of the answer
3 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolism and energy

    Nutrient and

    The and of nutrients for production, energy or cellular maintenance

    Where this hypothesis actsPre-existing invasive epithelial during repair in aging human

    Hypotheses on this target 1
    Nutrient uptake and metabolismInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Function preservation
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Inhibition

    Selectively interrupt or of material released by cell death

    With whatNot stated in the record

    HowIdentify a , then perturb or conversion, verify loss and test or suitable nutrient

    Possible result

    Expected in extra survival or production if death-derived material causally supports it

    From the recordAfter identifying a candidate limiting substrate, use orthogonal invader-specific uptake/conversion perturbations with target engagement and demonstrated loss of relevant flux

  2. Specialised cell of an organ

    Epithelial cells

    Cells that form epithelial tissue

    Where this hypothesis acts populations in aging human containing a pre-existing

    Hypotheses on this target 3
    Epithelial cellsFunction restoration. Hypotheses on this target 0Reprogramming. Hypotheses on this target 0Transplantation. Hypotheses on this target 0Elimination. Hypotheses on this target 22Proliferation. Hypotheses on this target 0
    • Function restoration
    • Reprogramming
    • Transplantation
    • Elimination2
    • Proliferation

    What is proposed

    Elimination

    Compare killing with retained debris against physical extraction and retention

    With whatPhysical or surgical intervention

    HowCompare retention, , killing with retained debris and extraction; and trace its release and use

    Possible result

    Possible extra invader survival or production when death supplies accessible, metabolically useful material

    From the recordCompare resident retention, viability-preserving suppression, killing with retained debris and physical extraction

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsEpithelial cells. Hypotheses on this target 3Epithelial cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolism
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Removing damaged cells could change what nearby dangerous cells have available to eat. The unexpected move is that killing a cell while leaving its remains nearby might nourish an already invasive neighbour, rather than helping it only by removing competition. This is a hypothesis generated by the pipeline, not a measured result in aging human tissue.

The proposed mechanism, link by link
  1. Killing leaves accessible remains locally, whereas extraction can carry that material away.
  2. The retained remains supply an additional beyond substances already released by living .
  3. An already invasive cell family takes up material from that pulse.
  4. The invasive cells use the material to build new cell components or release energy for maintenance.
  5. That use supports additional survival or cell production during repair; into surrounding tissue remains a separate outcome.
A picture for it

Clearing a kitchen can leave edible scraps behind, and those scraps can feed something already living nearby. Carrying everything away and leaving the scraps on the floor are different kinds of clearing.

Where the picture breaks: Cell remains are not automatically usable food. Their chemical contents, removal rate, accessibility and actual use must be measured, and dangerous cells can also benefit from changes unrelated to feeding.

  1. Master questionstep 01 of 04

    Human aging is the target of a search for ways to slow it radically.

    Rests on: The supplied goal sets radical slowing of human aging as the desired outcome; it supplies no particular biological explanation.

    Assumption

    The search takes radical slowing as a goal worth investigating. The supplied material does not establish that this degree of slowing is achievable.

  2. Goal pillarstep 02 of 04

    Age-related damage may become entrenched when defective forms of tissue renewal gain an advantage.

    Rests on: The connection requires an explanation of how an advantage in defective renewal preserves damage and contributes to human aging.

    Leap

    The master question supplies the goal but no basis for selecting this mechanism. The screened sources do not establish that defective renewal entrenches age-related damage.

  3. Gap questionstep 03 of 04

    Suppressing an expanding , a family of cells descended from one cell, might remove protective competitors and allow dangerous cells to invade surrounding tissue. The question concerns , the cell layers that cover surfaces and line organs, across repeated rounds of repair.

    Rests on: An advantage during tissue renewal makes competition relevant, but the proposed danger also requires some expanding cell families to restrain invasive neighbours.

    Leap

    The preceding stage does not explain why a cell family would protect against or why suppressing it would release dangerous neighbours. Those possibilities are posed for investigation rather than established.

  4. Hypothesisstep 04 of 04

    Killing while leaving accessible remains may provide extra nutrients that an already invasive cell family uses to survive or produce more cells during repair. This counts as feeding only if using that material causes the extra output and the available amount can plausibly support it.S3

    Rests on: The gap question supplies the removal-and-repair setting. A Nature Communications study from 2020 supports the narrower possibility that altered breast cancer can use scavenged nutrients to sustain multiplication under nutrient shortage; it does not establish feeding from locally killed during repair in aging human tissue.

    Supported by literature

What is carried, and what is not. One screened source, S3, provides partial support for the , use and growth portion of the mechanism: Nature Communications in 2020 reported scavenging-supported multiplication in altered breast cancer under nutrient shortage, not death-derived feeding during aging human tissue repair. S4 supplies cell-death background and S10 supplies a cancer-cell nutrient-dependence observation; neither establishes the proposed transfer, no supplied source establishes the complete sequence, and part of the hypothesis's test description is explicitly omitted from the provided input.S3S4S10

Where the reasoning is carried by something unstated · 3
  • Master question. The search takes radical slowing as a goal worth investigating. The supplied material does not establish that this degree of slowing is achievable.
  • Goal pillar. The master question supplies the goal but no basis for selecting this mechanism. The screened sources do not establish that defective renewal entrenches age-related damage. Establish the missing link before relying on this step.
  • Gap question. The preceding stage does not explain why a cell family would protect against or why suppressing it would release dangerous neighbours. Those possibilities are posed for investigation rather than established. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A chemical appearing in dangerous cells alongside extra growth could be mistaken for proof that dead cells fed them. The could remain in attached debris, while death-related signals cause growth; conversely, material burned for energy could help survival without leaving much in newly built cell components. What closes it: The proposed , which follows material using distinguishable forms of an element, must separate contamination from material incorporated into newly made cell components and from material broken down for energy. Feeding requires verified interruption and restoration of the relevant material use, coupled to absolute cell production or survival. If nutrient use cannot be separated from , the result supports limits on material transfer rather than a causal feeding claim.
  • A feeding effect created by nutrient-starved culture conditions could be read as an ordinary route in aging human tissue. Detectable transfer alone could also be credited with supporting more growth than its measured amount permits. What closes it: The design requires nutrient supply, fluid delivery and removal of dead material within defensible tissue conditions. A , an accounting of material entering, leaving and being used, must connect the accessible amount and rate to measured requirements and output. A nutrient needed only in small amounts still requires evidence that its availability limits output and that the supplied amount is sufficient.
  • An increased share of dangerous cells could be mistaken for extra dangerous-cell production when it merely reflects the loss of . Extra production could also be mistaken for , or attributed to feeding when removal instead reduces displacement of dangerous cells or changes the surrounding tissue. What closes it: The proposed comparisons must measure births, deaths and absolute cell amounts separately from dangerous-cell fractions and actual tissue crossing. They must also record successful replacement of dangerous cells, tissue function and the surrounding structural material. Restored restraint after replacement does not alone disprove feeding, because replacement cells could consume the nutrients or suppress cells that were fed.

What would make this wrong. For the tested conditions, the proposed feeding explanation would fail if the extra survival or cell production persisted unchanged after the relevant death-derived material use was demonstrably eliminated, with comparable injury and other repair conditions. It would also fail if measured access, and usable were insufficient to support the claimed contribution. Failure of one block or absence of tissue alone would not supply that result, and failure in one model would not disprove every conditional version of the proposal.

What it would change. If the mechanism held, attempts to slow human aging by removing harmful cell populations would need to distinguish killing that leaves usable remains from removal that carries material away or clears it promptly. Short-term nutrient delivery to dangerous neighbours would become a separate outcome to measure alongside improved tissue repair. Even a positive result in the proposed older-donor tissue model would not establish that this route occurs broadly in living humans, causes , or changes the overall rate of aging.

Sources read · 3

9 literature searches, 6 full texts, 4 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S3Partly answers it

Macropinocytosis confers resistance to therapies targeting cancer anabolism. · Nature communications · 2020

“Here we demonstrate that breast cancer cell lines with oncogenic mutations that activate KRAS or the PI3K pathway fuel proliferation in nutrient-limiting conditions using not just amino acids, but also sugars, lipids, and nucleotides scavenged via macropinocytosis.”

Does not settle: The source does not establish this effect in aging human epithelium during repair, with locally killed resident cells, physiological clearance or debris retention, or at a quantitatively plausible in-tissue scale. The quoted finding is limited to oncogenically altered breast cancer cell lines under nutrient-limiting conditions.

S4BackgroundAbstract only

Cell death at the intestinal epithelial front line. · The FEBS journal · 2016

“In this review we discuss cell death processes in the intestinal epithelium in health and disease, with special emphasis on cell death triggered by the tumour necrosis factor receptor family.”

Does not settle: The abstract does not establish that retained epithelial corpse material creates an incremental nutrient pulse, that an invasive lineage assimilates or catabolically uses death-derived material, or that such use causally increases survival or proliferation during repair. It provides no evidence for aging human epithelium, quantitative flux, death-mode or clearance effects, local uptake, or changes in clone fractions.

S10Background

Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma · Clinical and Translational Medicine · 2022

“Of note, the addition of glucose to the media had only a small benefit for cell viability when glutamine was present, showing the dependency of 786‐O cells on glutamine for cell survival, as described before”

Does not settle: The source does not study dead resident cells, retained corpse material, death-derived nutrient flux, epithelial repair, aging human epithelium, invasive-lineage uptake, isotope-resolved assimilation, clearance or removal conditions, or whether corpse-derived nutrients causally increase survival or proliferation at a quantitatively plausible scale.

The gap this hypothesis explains

Two established results predict opposite outcomes, and both cannot be right.

Does suppressing expanding cell families in aging human linings promote or improve repeated repair?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

During human aging, can suppressing expanding accelerate dangerous by removing protective competitors, and what distinguishes this from removal of genuinely dysfunctional across repeated repair?

What this question is asking

The question concerns growing families of related cells in the tissues that cover body surfaces and line organs during human aging. It asks whether suppressing those families could remove cells that restrain dangerous neighbors, allowing those neighbors to spread into surrounding tissue. It also asks how that outcome differs from removing cell families that actually damage tissue function through repeated cycles of injury and repair. The comparison is suppression versus leaving the families in place, assessed together for , protection from neighboring cells, and tissue function over months to years. The question assumes that some expanding families provide protection and that expansion alone does not establish harmful behavior; the supplied sources do not establish that distinction in aging human tissues.

What the terms mean
Epithelium and epithelial cells
is tissue that covers body surfaces or lines organs; epithelial cells make up that tissue. These are the cells whose expanding families the question proposes suppressing.
Clone, cell family, and lineage
A is a family of cells descended from a common ancestor cell; refers to that ancestry and its . These terms describe relatedness, not whether the cells are healthy, harmful, or protective.
Clonal expansion
An increase in the number or tissue share of cells belonging to one family. Expansion alone does not specify what happens to tissue function or .
Suppression
Reducing a cell family's growth or abundance. The supplied question does not specify a method or establish that suppression removes the family completely.
Aged human mosaic
An aging human tissue containing a mixture of cell families with different characteristics. The question asks how changing that mixture affects function and .
Cell competition and protective competitor
Cell competition describes interactions that affect which cells persist or expand alongside others. A protective competitor is a cell family whose presence restrains dangerous neighbors; that protective role is an assumption to evaluate here.
Ecological release
Expansion or spread that becomes possible after a restraining competitor is removed. In this question, it names the proposed causal link between suppressing one cell family and increased by another.
Invasion
Spread of cells into surrounding tissue beyond their previous location. It differs from simply increasing the number of cells within an existing tissue region.
Stroma and stromal signaling
Stroma is the supporting tissue around other tissue structures. means messages from that supporting tissue that influence nearby cells; the premise proposes that such messages can enhance .
Dysfunctional lineage
A cell family that impairs tissue work, appropriate control of growth, or the performance of specialized cell roles. It is a functional description, not a designation established merely by expansion.
Specialization, growth control, and repeated repair
means cells performing their particular tissue jobs; means regulation of when and how much cells multiply. Repeated repair means successive episodes of restoring damaged tissue, across which the question requires function to be maintained.
Adhesion
Attachment between cells. S4 reports reduced attachment alongside increased competition, without establishing the aging-related consequences of competitor removal.
Epithelial-to-mesenchymal transition
A change in which lining cells acquire characteristics associated with less tightly attached, more mobile cell states. The term covers a range of changes rather than a single all-or-nothing switch; S3 reports its induction, not the suppression outcome asked about here.
Gene, genetic change, and protein
A gene is a stretch of inherited cellular information, and a genetic change is an alteration in that information. Proteins are molecules that carry out many cellular tasks; the supplied studies include removal of a gene and induction of a protein, which are different interventions from suppressing an expanding cell family.
Cell line and transplanted tumor
A is a population of cells maintained for study outside its original tissue. A transplanted tumor is tumor tissue or tumor-forming cells placed into a recipient for study; neither system by itself establishes effects during human aging.
What the question takes for granted
Premise could not be checked
can constrain tumors, while can enhance , so suppressing expanding in aged human may remove protective competitors rather than genuinely dysfunctional .

The assumption concerns families of related cells in body coverings and organ linings, alongside the supporting tissue around them. It proposes that competition among the lining cells can restrain dangerous growth while messages from surrounding support cells can encourage . If that distinction holds during human aging, the consequences of suppressing a growing cell family would depend on what it does to its neighbors and to tissue function, rather than simply how much it expands.

The supplied evidence does not establish the combined premise in aging human tissues. S1 describes different patterns of altered-cell growth in different regions of mouse skin, without testing removal of protective competitors. S4 reports reduced and increased competition after induction of a protein in cells surrounding a cancer, but does not establish that this competition protects against or that suppressing a competitor releases . S3 and S8 do not test that distinction either. This small set of background sources is too indirect to judge the premise; it does not refute it.S1S3S4S8

The same question asked without the part nothing read establishes:

  • During human aging, does suppressing expanding families of lining cells increase, decrease, or leave unchanged and tissue function across repeated repair?
  • What distinguishes expanding families of lining cells whose suppression increases from those whose suppression improves tissue function across repeated repair?
What turns on the answer
  • Suppression increases Under the proposed protective-competition mechanism, suppression removes cells that restrain dangerous neighbors, allowing those neighbors to spread further into surrounding tissue. A in the targeted family would then coexist with increased danger, so reduced expansion alone would not establish a beneficial outcome.
  • Suppression improves repair without increasing If the targeted family impairs tissue function, its suppression could reduce that interference during subsequent repair. Improved function without increased would support a beneficial effect of suppression in that setting, although it would not by itself establish the precise mechanism.
  • Suppression improves function but increases An expanding family could, within the question's proposed framework, impair tissue work while also restraining dangerous neighbors. Removing it could therefore improve repair and increase at the same time, making either measurement alone an incomplete account of the outcome.
  • Suppression changes neither outcome If neither nor tissue function changes, suppressing expansion would show no benefit or harm on those measured outcomes. That result alone would not establish whether the family had no relevant role or whether other cells maintained its effects.
Why it matters

The proposed causal chain begins with suppressing an expanding cell family, which changes which cells remain in the tissue. If that family restrains dangerous neighbors, removing it could remove a barrier to their spread into surrounding tissue. If the family instead impairs normal tissue work, removing it could have a different consequence for repeated repair. Mistaking protective growth for harmful growth could therefore increase , while mistaking harmful growth for protection could preserve impaired tissue function. These are conditional consequences of the question's proposed mechanism, not outcomes demonstrated by the supplied sources.

What is already established

RL-1 can constrain tumors, while RL-1 can enhance ; human lacks .

What would have to be true

Across months–years of renewal, must not progressively impair , or function; is permissible.

What is missing

The sign of in aged human is unknown when protection, tissue function and are evaluated together.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

SCOUT 2 from and , conditional: In aging human , killing a while retaining locally accessible corpse material may create an incremental that a pre-existing uses through or to support extra survival or during repair. This is material feeding only if access to and of that pulse causally support the extra output at a quantitatively plausible scale. Extraction that carries away, prompt and with retained debris are different ; physical removal does not inevitably supply nutrients. or can already , so the claim concerns an incremental , not zero . A functionally irrelevant killed could supply the same effect only if the chemical composition, accessible amount, , and are equivalent. Nutrient-driven growth can coexist with , loss of , or changes, and need not produce . Adequate might improve tissue quality after removal while an feeding contribution occurs. No / is assigned to ; the remains unverified. Any effect on dangerous must be measured separately from and .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

Proposed common-condition test: in a defined older-donor epithelial mosaic with a pre-existing , initially exclude microbes and . Compare retention, , killing with retained debris and physical extraction, recording local coverage, , mature function, , nutrient delivery, and . , , then measure the amount, and released, cleared and reaching invaders. Trace through into purified newly synthesized invader and, for survival/maintenance, quantify and energetic use; exclude residual /, , undegraded engulfed material and . Add only in separate to distinguish . Quantify absolute births, deaths, net newly produced and invasive events. Use carbon/nitrogen or , with inputs, recovered corpse material and metabolic losses, to ask whether accessible assimilated material and its measured plausibly account for extra output; a need not supply most , but its necessity and quantitative capacity must be shown. Test measured under baseline-supporting, physiologically defensible nutrient/ conditions; dependence manufactured by starvation does not establish an ordinary-human route. After identifying a candidate , use /conversion with and demonstrated loss of relevant , the , and compare equally injured invaders supplied with non-corpse nutrients. alone cannot exclude a general or effect, and one block is not a complete interruption. Under the hypothesis, selective loss of reduces the extra production/survival component and its it. at measured is supplementary: separately interrupt versus where feasible and test alternative nutrient to distinguish instructions from feeding. If drives extra growth despite adequately verified loss of , the feeding contribution is bounded; if selective separation is impossible, plus growth does not establish nutrition. High- or can consume the pulse or suppress fed invaders, so restored restraint does not disprove feeding. Measure actual and in such ; may separately determine crossing. alone does not exclude nutrition, and alone does not exclude redundant . Additional required and bounded interpretations: For the survival branch extend to , , and energetic/maintenance use, while separating contamination and . Couple measured to absolute survival/death and selective loss/; absence of retained alone cannot exclude , and catabolic alone cannot establish its causal benefit. Bound accessible amount, rate and plausible output supported using the measured requirement/ and uncertainty; test physiologically defensible availability with alternative nutrient and -selective loss/ when feasible. Do not equate with causal contribution or claim a numerical capacity absent measurements. Compare tracked , absolute growth and in matched normal and tumor contexts with recorded and perturbation/. Independently test and mature/; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track –invader contacts, direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/ and mature/barrier outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and selective perturbation/ within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native mechanisms and does not establish absence of new merely because none were intended. Quantify release, delivery, and use versus /suppressed- , and test whether a limiting material input causes extra survival or production after controlling while allowing to vary. Equivalent dead mass from another predicts equivalence only when species, composition, , and local availability are matched. Demonstrate loss of the relevant , intact and , and -specific . If or inseparable prevents these , report transfer plus and bounds, not proven ; a single perturbation does not reject the mechanism. Measure local release, availability, and output over an explicitly justified delivery/ range anchored to the chosen tissue once such data exist. Report the range as unvalidated until measured. An isolates direct transfer; separately add /recycling and record net effects before making any inference. Current finding-specific qualification: Material feeding can cause . Preserving in the must not mean caused by restored limiting material or energy. The rival is instruction independent of that limiting material function, not every response to nutrition. Where selective separation is feasible, compare material-use loss and or suitable nutrient restoration while preserving independent instructive exposure and matched-injury/alternative-nutrition competence, allowing downstream nutrient-state responses to vary. Attribute assimilative and catabolic/maintenance to invaders with the existing , and separate- . If material and instructive roles cannot be separated, report transfer, and -specific rather than proven .

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies a measurable decrease in extra production or survival following selective material-flux interruption, with rescue upon restoration. No rival prediction is supplied. The text states observable possible outcomes of resident add-back: pulse consumption or suppression of fed invaders. These qualitative outcomes are measurable, although much of the chunk specifies measurements and limits on interpretation. No rival prediction is supplied. The prediction states a conditional equivalence in outcomes for dead mass from different lineages under explicitly matched conditions. This qualitative comparison is measurable. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

and extracellular/invader measurements can test access and scale before assigning a . No released , limiting amount, selective invader target or feeding effect is supplied. and inseparable may prevent a decisive intervention; report material-transfer bounds rather than in that case. Equal corpse mass or cannot guarantee equal invader . Check both intact baseline and equally stressed non-corpse growth, and ; could create an absent- dependency. No dietary or follows.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

Proposed common-condition test: in a defined older-donor epithelial mosaic with a pre-existing , initially exclude microbes and . Compare retention, , killing with retained debris and physical extraction, recording local coverage, , mature function, , nutrient delivery, and . , , then measure the amount, and released, cleared and reaching invaders. Trace through into purified newly synthesized invader and, for survival/maintenance, quantify and energetic use; exclude residual /, , undegraded engulfed material and . Add only in separate to distinguish . Quantify absolute births, deaths, net newly produced and invasive events. Use carbon/nitrogen or , with inputs, recovered corpse material and metabolic losses, to ask whether accessible assimilated material and its measured plausibly account for extra output; a need not supply most , but its necessity and quantitative capacity must be shown. Test measured under baseline-supporting, physiologically defensible nutrient/ conditions; dependence manufactured by starvation does not establish an ordinary-human route. After identifying a candidate , use /conversion with and demonstrated loss of relevant , the , and compare equally injured invaders supplied with non-corpse nutrients. alone cannot exclude a general or effect, and one block is not a complete interruption. Under the hypothesis, selective loss of reduces the extra production/survival component and its it. at measured is supplementary: separately interrupt versus where feasible and test alternative nutrient to distinguish instructions from feeding. If drives extra growth despite adequately verified loss of , the feeding contribution is bounded; if selective separation is impossible, plus growth does not establish nutrition. High- or can consume the pulse or suppress fed invaders, so restored restraint does not disprove feeding. Measure actual and in such ; may separately determine crossing. alone does not exclude nutrition, and alone does not exclude redundant . Additional required and bounded interpretations: For the survival branch extend to , , and energetic/maintenance use, while separating contamination and . Couple measured to absolute survival/death and selective loss/; absence of retained alone cannot exclude , and catabolic alone cannot establish its causal benefit. Bound accessible amount, rate and plausible output supported using the measured requirement/ and uncertainty; test physiologically defensible availability with alternative nutrient and -selective loss/ when feasible. Do not equate with causal contribution or claim a numerical capacity absent measurements. Compare tracked , absolute growth and in matched normal and tumor contexts with recorded and perturbation/. Independently test and mature/; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track –invader contacts, direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/ and mature/barrier outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and selective perturbation/ within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native mechanisms and does not establish absence of new merely because none were intended. Quantify release, delivery, and use versus /suppressed- , and test whether a limiting material input causes extra survival or production after controlling while allowing to vary. Equivalent dead mass from another predicts equivalence only when species, composition, , and local availability are matched. Demonstrate loss of the relevant , intact and , and -specific . If or inseparable prevents these , report transfer plus and bounds, not proven ; a single perturbation does not reject the mechanism. Measure local release, availability, and output over an explicitly justified delivery/ range anchored to the chosen tissue once such data exist. Report the range as unvalidated until measured. An isolates direct transfer; separately add /recycling and record net effects before making any inference. Current finding-specific qualification: Material feeding can cause . Preserving in the must not mean caused by restored limiting material or energy. The rival is instruction independent of that limiting material function, not every response to nutrition. Where selective separation is feasible, compare material-use loss and or suitable nutrient restoration while preserving independent instructive exposure and matched-injury/alternative-nutrition competence, allowing downstream nutrient-state responses to vary. Attribute assimilative and catabolic/maintenance to invaders with the existing , and separate- . If material and instructive roles cannot be separated, report transfer, and -specific rather than proven .

  • What would separate them

    Cell fusion may restore growth control through resident genes in aging epithelial tissue predicts: Proposed common-condition test: begin in older-donor of one specified epithelial site, with traceable /invader , measured local contacts, successful , baseline nutrient delivery, and . First live-track two becoming one , then establish , , / and subsequent ; exclude , , undegraded , or and . Quantify and whether and the restrained could account for the ; an undetected rare event gives a . Authentic must precede , but a necessary but not uniquely sufficient is loss of a nominated functional within an established followed by release of , and followed by restored restraint, with matched , history and generic , measuring -dependent changes without matching them away. Compare appropriate same- to separate functional from generic extra-DNA or . If identity remains unknown, report -associated only. After that, a validated -specific should reduce new protective formation and increase invader-derived output relative to , provided , , , , replacement hazard, nutrient access and remain comparable. Test a new invader challenge separately from already formed . should retain only the -attributable protection within the window where actual encounters, and mature function persist. Track late , , mature contribution and independently of and cell number. A selective / with adequate limits the proposed contribution in this setting; generic -dependent favors a -stress alternative. can reveal an additional contribution, including retained , and geometry; they do not eliminate unless validated / add no effect within those . Additional required and bounded interpretations: Compare tracked , absolute growth and in matched normal and tumor contexts with recorded and perturbation/. Independently test and mature/; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track –invader contacts, direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/ and mature/barrier outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and selective perturbation/ within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native mechanisms and does not establish absence of new merely because none were intended. First calibrate and live-track spontaneous two-parent-to-one events, phase and , and follow viability and before attempting tests. If none are detected, give a tissue/window/-dependent ; missing or insufficiently detectable events leave wider-subset support unknown. Conditional on , of the nominated deficient function should reinstate -mediated restraint, whereas matched and independent test or . Measure changes as possible , distinguishing them from generic . If selectivity, viability or defect identity cannot be established, report -associated or unresolved identification rather than rejection or proven . Estimate per time and their descendant output avoided per event with uncertainty, including unfused invaders and persistence/loss. Integrate these contributions through repairs and compare with the observed ; sustained arrested- accumulation alone cannot account for a formation-mediated protective . Before the , pilot and a window based on actual local contacts, incidence, and mature/, then independently validate those conditions during the comparison. Retained -attributable protection in that window does not predict months–years of adequate replenishment; follow repeated repair separately and call the isolated comparison inconclusive if its fail. Compare cumulative invasive , persistence/ and mature tissue contribution across successive repairs, with late chromosome and tracking. Report the observed and remaining explicitly; no early or arbitrary finite certifies long-term safety. Current finding-specific qualification: The avoided output of a fused invader is an unobserved : an arbitrary unfused invader need not be because may select contact histories and cell states. A formation-mediated field contribution remains conditional on a justified comparable-ancestry/history , not on . Constrain avoided descendant output using comparable and pre-event contact/state histories together with selective formation loss/; report residual and if comparability fails. Integrate incident events, output, persistence/loss, late and unfused over the same . No event frequency or quantitative protective effect is supplied.

  • What would separate them

    Resident daughter cells may restrain epithelial invaders by replacing their renewing positions predicts: Proposed common-condition test: in a older-donor epithelial mosaic of one site, track a complete : division, and , , , death, vacancies and actual replacement of invader . Keep invader , initial composition, , baseline nutrients and comparable and measure local contact geometry, density, cell size, and . First test whether gross J_R predicts directly observed h_RI at all. Then reversibly alter output with a and during the measured window before mature function or coverage diverges, with direct invader-exposure . If the mechanism operates, a in successful h_RI should reduce position-loss events and increase absolute renewing-invader growth by the event-accounted amount when other rates are unchanged; restoring h_RI with competent cells should restore that component of restraint. Equal J_R alone does not establish equivalent replacements, and no mutation-count-independent claim is made without equivalent contacts, and function. Estimate from , predict , and vary geometry explicitly rather than absorbing every result into kappa_R. Gross production changes with no h_RI change and no growth effect favor a over a transferable . Coupled mechanical and replacement effects support and limit an independent . Measure mature output and independently; a lower g_I cannot compensate for their deterioration. If or feeding interruption removes an excess while h_RI stays low, this limits loss as a sufficient or dominant cause only when invader growth capacity is preserved. Nutrients can increase lambda_I or survival enough to overcome high h_RI without disproving displacement. Cross that preserve both and allow events; effects may alter h_RI or other rates and can coexist, while a selective h_RI bounds this contribution. Report SPV_9 with and anatomical crossing separately. Additional required and bounded interpretations: Before observing held-out net growth, estimate on other repairs, then integrate their predicted and . Compare predicted absolute I and separate tissue with observations. A failed limits that , not the possibility of displacement; from the same outcome episode is bookkeeping, not . Follow P_R(t), , D_R survival/lifespan, tissue-specific mature function, and reserve available at the next repair jointly. Integrate and loss over time; a lower or higher J_R does not establish beneficial aging renewal or adequate . Track divisions, , and mature survival separately; audit / and include their or restrict the model to a justified . Estimate time/geometry-conditioned rates and integrate held-out repair trajectories with uncertainty, preserving specialized function as an independent outcome. Directly count per measured area/time and separately follow which reach and causally replace invader positions. Record changing area and boundaries; compare J_R with the event-resolved hazard in held-out geometry/time , allowing no relation or changing kappa_R. Freeze and before , including and repair-stage changes; use observable starting state and prespecified inputs. Recounting all held-out afterward checks accounting only. If no useful stable relation survives, retain event-caused displacement conditionally and reject or bound that , not replace its mechanism. invader-derived membership and count each descendant once in a , track renewing and and dynamics, and report SPV_9 per year separately from absolute growth and crossing. Check observed count consistency and uncertainty; changing fractions or mutation counts alone cannot establish or whole-human aging benefit. Compare tracked , absolute growth and in matched normal and tumor contexts with recorded and perturbation/. Independently test and mature/; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track –invader contacts, direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/ and mature/barrier outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and selective perturbation/ within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native mechanisms and does not establish absence of new merely because none were intended. Use plus selective output/ perturbation and , comparing the ordering of position occupancy, and invader exit. uncertain-order cases and bound their influence; preserved area or gross J_R alone cannot identify replacement causation. Calibrate observation and missed events; report growth bounds under plausible assignments of ambiguous events without allocating them to fit the equation. Track displaced as differentiated, basally displaced, dead or unresolved separately: loss from the is not automatically loss of the or anatomical safety. Current finding-specific qualification: The applies to a or justified with and represented flows; it is not a realized or an . For , dE[I_s]/dt=E[g_s I_s]+E[], and E[g_s I_s] generally differs from E[g_s]E[I_s]. A requires independent justification. and validate the on training repairs or integrate an explicit ; propagate event, rate and into held-out and . Report and separately, without replacing the already defined by the . Compare equally prespecified contact/occupancy models. Match ; measure mechanics caused by daughter as part of its total displacement effect instead of that mediator. A failed or limits that , not event-caused displacement.

  • What would separate them

    Loss of mucosal barriers may let microbial toxins create mutations that drive invasion predicts: Proposed common-condition test: use a defined older-donor epithelial mosaic supporting documented and repair, with , deeply characterized split across conditions. Cross retention, and controlled small-area removal with verified , and conditions plus . The matched pair is an experimental target: verify microbial growth, , , and proximity; equal bacterial counts are not equal delivered dose. Match initial deletion, non- injury, starting , baseline nutrients, initial corpse material and ; downstream -induced corpse release is not matched away in the . Measure and local activity/contact over time and do not force downstream -mediated injury equal, because it lies on the proposed . First establish whether removal actually increases delivered exposure and /damage in surviving . If it does, follow barcodes, repeated samples and to nominate acquired after exposure and before , reporting rather than claiming every rare pre-existing was absent. A new or plus expansion is insufficient. After withdrawal, compare in a shared uninjured and ; reconstruct a nominated in the appropriate or correct it in the descendant, with matched , to test causal invasive behavior and possible cooperation with pre-existing . Under the hypothesis, specific interruption reduces the acquired--mediated component, and restoration of verified delivered exposure is predicted to restore its population-level contribution under a , not the identical or descendant in every . alone can also reflect selective killing or growth of pre-existing ; ancestry and causality distinguish these routes. or should lack this -mediated new- component, while other release mechanisms can persist. A finite negative result bounds the tested dose/time and detectable frequency, not all late events. Measure absolute descendant production, with , mature barrier and separately. -dependent without required new causal supports a contribution and can coexist with . Additional required and bounded interpretations: Measure local delivered dose, activity/contact, /damage, cell death/ and surviving descendant in under matched and conditions. Bound pre-existing ancestry and require separate -function evidence before predicting invasive ; current cannot establish past exposure. Compare tracked , absolute growth and in matched normal and tumor contexts with recorded and perturbation/. Independently test and mature/; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track –invader contacts, direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional perturbation/ and mature/barrier outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and selective perturbation/ within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native mechanisms and does not establish absence of new merely because none were intended. Compare retention, suppression and the specified removal procedure using delivered activity/contact, functional barrier measures and surviving-renewal-cell damage. Proceed to the only if that first link is supported in the proposed model; absence under rapid bounds that procedure, not all epithelial removal. Preserve , baseline detection bounds, and post-exposure timing. Test nominated new changes in the relevant ancestral/descendant , with existing characterized, and require a causal contribution to sustained after in a justified common rather than or alone. Across independent ancestral compare and distributions of surviving , with uncertainty, delivered dose, cell loss/ and adequate follow-up recorded. Restoration means of the within a justified ; a finite unmatched is not , and no universal is asserted. Report both total-effect and with their distinct intervention conditions; track all initial , death and surviving , then report as such. Preserve the -to-death-to-feeding chain in total-effect comparisons and use ancestral matching rather than treating as . Where indicated, test justified sets and characterized with matched . Retain the exposure-to-ancestry chain and test sustained in a shared justified for the original tissue. enabled only by an artificial does not establish consequential caused by removal in aging tissue. Current finding-specific qualification: restoration remains a , with distinct per initial , per exposure and conditional on survival. A pulse-clamped is a separate only if the clamp is feasible and does not independently alter delivered , susceptibility or relevant repair functions; feasibility is not established. follow-up and report the probability of at least one per starting , absolute counts per initial , and any with its exposure and uncertainty; separately and follow all initial including deaths/. Validate any pulse clamp for exposure and susceptibility; if validation fails, omit its isolated causal interpretation while retaining the with -induced injury, death and feeding intact. Validate ecology and delivery; alone still does not distinguish new- causality from selection.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.